Search

everythinglearnresearchcommunity

for

Search:↓

Boosting mitochondrial energy production with supplements like acetyl-L-carnitine may improve aging-related cellular function and health conditions.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

There's no significant link between blood fat levels and male pattern baldness.

New materials help control stem cell growth and specialization for medical applications.

SLVs help maintain muscle stretch sensitivity and could aid in treating hypertension and muscle spasticity.

Severe and early hair loss may indicate a higher risk of heart disease.

Finasteride worsens heart damage from nandrolone decanoate but protects against cell damage.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

Eating apples can help prevent heart disease, cancer, and other conditions because they have healthy plant chemicals.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

A study found that minoxidil can damage the hearts of dogs and pigs, cautioning its use in humans.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

The document concludes that individuals with a rare genetic disorder linked to the AEBP1 gene may experience a unique type of hair loss and should be monitored for heart issues.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Minoxidil treats high blood pressure and side effects can be managed.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Cantu syndrome, which causes excessive hair growth and skin issues, is due to a mutation in the ABCC9 gene, and understanding this could help develop new treatments for hair diseases.

Juvenile dermatomyositis can worsen quickly and needs strong treatment.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

A genetic mutation linked to longer life and less disease was found in the Amish, and a drug is being developed to replicate these benefits.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

Lung repair involves both dedicated and flexible stem cells, important for developing new treatments.

Minoxidil use during pregnancy may cause fetal harm.